ImmunoPrecise Antibodies (IPA) Institutional Ownership → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free IPA Stock Alerts $1.15 -0.05 (-4.17%) (As of 05/15/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.07MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$58.20K Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/29/2024 Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023 Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023 Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023 Bank of Montreal Can208,110$668K0.0%N/A0.831% 5/9/2023 Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023 Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 1/31/2023 Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022 Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% 10/21/2022 Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022 Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022 Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022 Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022 Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022 Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022 National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021 Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021 Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021 Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021 Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021 Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021 Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021 JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021 Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021 Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021 Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% 5/17/2021Ikarian Capital LLC150,000$1.47M0.0%N/A0.783% 5/14/2021 Credit Suisse AG33,423$328K0.0%N/A0.174% 5/13/2021AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494% 5/12/2021 JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231% 5/11/2021 Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021% 4/21/2021 Ingalls & Snyder LLC517,195$5.08M0.2%+30.5%2.705% 2/19/2021 JPMorgan Chase & Co.19,505$292K0.0%N/A0.116% 2/17/2021Jane Street Group LLC40,774$610K0.0%N/A0.243% 2/5/2021 Orion Portfolio Solutions LLC15,821$237K0.0%N/A0.094% 1/27/2021 Ingalls & Snyder LLC396,425$5.93M0.3%N/A2.358% Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here.(Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($2.19M), Bank of Montreal Can ($668K), Ikarian Capital LLC ($237K), Cibc World Market Inc. ($183K), and Gradient Capital Advisors LLC ($107K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors. What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies stock? The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($371.61K), Bank of Montreal Can ($275.50K), Cibc World Market Inc. ($47.43K), Rathbones Group PLC ($14K), and Gradient Capital Advisors LLC ($6.81K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 715,348 shares in the last 24 months. This purchase volume represents approximately $1.93M in transactions. Which ImmunoPrecise Antibodies major shareholders have been selling company stock? The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K), and Ikarian Capital LLC ($16.22K). How much institutional selling is happening at ImmunoPrecise Antibodies? Institutional investors have sold a total of 48,019 shares in the last 24 months. This volume of shares sold represents approximately $119.82K in transactions. Related Companies: Spruce Biosciences Major Shareholders Fortress Biotech Major Shareholders Viracta Therapeutics Major Shareholders BriaCell Therapeutics Major Shareholders Daré Bioscience Major Shareholders Acurx Pharmaceuticals Major Shareholders Marker Therapeutics Major Shareholders Apollomics Major Shareholders ProMIS Neurosciences Major Shareholders CASI Pharmaceuticals Major Shareholders This page (NASDAQ:IPA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
